QCM
DAWN

Quantinno Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Quantinno Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$376K Buy
17,556
+1,568
+10% +$22.1K ﹤0.01% 2911
2025
Q4 		$149K Buy
15,988
+1,182
+8% +$9.88K ﹤0.01% 3098
2025
Q3 		$104K Buy
14,806
+3,525
+31% +$24.3K ﹤0.01% 2876
2025
Q2 		$73.3K Buy
+11,281
New +$77.6K ﹤0.01% 2537

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Quantinno Capital Management's DAWN Position: Q1 2026 in Review

Quantinno Capital Management increased its Day One Biopharmaceuticals (DAWN) stake by 9.8% in Q1 2026, buying an estimated $22.1K and bringing the position to 17,556 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #2911.

Quantinno Capital Management first reported a position in DAWN in Q2 2025 and has held it in 4 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Quantinno Capital Management held 17,556 shares of Day One Biopharmaceuticals worth $376K as of Q1 2026.
  • Quantinno Capital Management bought 1,568 Day One Biopharmaceuticals shares in Q1 2026, an estimated $22.1K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2911 holding.
  • Quantinno Capital Management first reported a position in Day One Biopharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.